Gary Chris Fillmore

595 total citations
12 papers, 439 citations indexed

About

Gary Chris Fillmore is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Gary Chris Fillmore has authored 12 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Immunology. Recurrent topics in Gary Chris Fillmore's work include T-cell and Retrovirus Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Ubiquitin and proteasome pathways (2 papers). Gary Chris Fillmore is often cited by papers focused on T-cell and Retrovirus Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Ubiquitin and proteasome pathways (2 papers). Gary Chris Fillmore collaborates with scholars based in United States, Brazil and South Korea. Gary Chris Fillmore's co-authors include Carl T. Wittwer, D. J. H. Garling, David R. Hillyard, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim, David K. Crockett, Zhaosheng Lin, Ryan S. Robetorye, Sandra D. Bohling and Tae Hyun Um and has published in prestigious journals such as Nucleic Acids Research, Blood and Analytical Biochemistry.

In The Last Decade

Gary Chris Fillmore

11 papers receiving 412 citations

Peers

Countries citing papers authored by Gary Chris Fillmore

Since Specialization

Citations

This map shows the geographic impact of Gary Chris Fillmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Chris Fillmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Chris Fillmore more than expected).

Fields of papers citing papers by Gary Chris Fillmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Chris Fillmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Chris Fillmore. The network helps show where Gary Chris Fillmore may publish in the future.

Co-authorship network of co-authors of Gary Chris Fillmore

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Chris Fillmore. A scholar is included among the top collaborators of Gary Chris Fillmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Chris Fillmore. Gary Chris Fillmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Advances and current concepts on Eph receptors and ephrins in upper digestive tract cancers 2025 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Albina Altemani, Fernanda Viviane Mariano, Gary Chris Fillmore, Érika Said Abu Egal	0
2	Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets 2024 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Albina Altemani, Fernanda Viviane Mariano, Heloisa P. Soares, Gary Chris Fillmore, Érika Said Abu Egal	2
3	Hematopoietic colony-stimulating factors in head and neck cancers: Recent advances and therapeutic challenges 2023 ·Cytokine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Luiz Paulo Kowalski, Albina Altemani, Gary Chris Fillmore, Fernanda Viviane Mariano, Érika Said Abu Egal	1
4	Apoptosis of t(14;18)-positive lymphoma cells by a Bcl-2 interacting small molecule 2009 ·Journal of Hematopathology ·(unknown), (unknown), Stephen D. Jenson, Gary Chris Fillmore, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	1
5	The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways 2009 ·Blood ·Megan S. Lim, M. Carlson, David K. Crockett, Gary Chris Fillmore, (unknown), (unknown), Sheryl R. Tripp, George Z. Rassidakis, L. Jeffrey Medeiros, Philippe Szankasi, Kojo S.J. Elenitoba‐Johnson	43
6	Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by *in vitro* and *in silico* proteomics 2005 ·PROTEOMICS ·David K. Crockett, Gary Chris Fillmore, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	29
7	Expression of Akt (protein kinase B) and its isoforms in malignant lymphomas 2005 ·Leukemia & lymphoma ·Gary Chris Fillmore, Qifu Wang, Michael J. Carey, (unknown), Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	29
8	Comparative Microarray Analysis of Gene Expression During Activation of Human Peripheral Blood T Cells and Leukemic Jurkat T Cells 2003 ·Laboratory Investigation ·Zhaosheng Lin, Gary Chris Fillmore, Tae Hyun Um, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	29
9	Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18) 2002 ·Journal of Molecular Diagnostics ·Ryan S. Robetorye, Sandra D. Bohling, James P. Morgan, Gary Chris Fillmore, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson	22
10	Gene expression profiling of cell lines derived from T‐cell malignancies 2002 ·FEBS Letters ·Gary Chris Fillmore, Zhaosheng Lin, Sandra D. Bohling, Ryan S. Robetorye, (unknown), Stephen D. Jenson, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	17
11	Minimizing the time required for DNA amplification by efficient heat transfer to small samples 1990 ·Analytical Biochemistry ·Carl T. Wittwer, Gary Chris Fillmore, D. J. H. Garling	148
12	Automated polymerase chain reaction in capillary tubes with hot air 1989 ·Nucleic Acids Research ·Carl T. Wittwer, Gary Chris Fillmore, David R. Hillyard	118

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact